Impax Laboratories Confirms Patent Challenge Relating To TRILIPIX(R) Delayed-Release Capsules, 135 Mg And 45 Mg

Main Category: Cholesterol
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 17 Mar 2010 - 0:00 PDT



Current ratings for:
'Impax Laboratories Confirms Patent Challenge Relating To TRILIPIX(R) Delayed-Release Capsules, 135 Mg And 45 Mg'

Patient / Public:1 star

1 (1 votes)

Healthcare Prof:not yet rated


Impax Laboratories, Inc. (NASDAQ: IPXL) confirms that it has initiated a challenge of the patent listed by Abbott Laboratories and Fournier Laboratories Ireland Ltd. in connection with its TRILIPIX® (choline fenofibrate) delayed-release capsules, 135 mg and 45 mg.

Impax filed its Abbreviated New Drug Application ("ANDA") containing a paragraph IV certification for a generic version of TRILIPIX® with the U.S. Food & Drug Administration ("FDA"). Following receipt of the notice from the FDA that Impax's ANDA had been accepted for filing, Impax notified the New Drug Application holder and patent owner of its paragraph IV certification.

On March 12, 2010, Abbott Laboratories and Fournier Laboratories Ireland Ltd. filed suit for patent infringement against Impax in the United States District Court for the District of New Jersey. This action formally initiates the patent challenge process under the Hatch-Waxman Act. Based on the filing date of the ANDA, the Company believes that it is the first to file an ANDA with a paragraph IV certification and expects to be entitled to 180 days of market exclusivity.

Once the ANDA is approved by FDA, Global Pharmaceuticals, Impax's generic division, will commercialize the products.

TRILIPIX® helps reduce cholesterol and triglycerides (fatty acids) in the blood. According to Wolters Kluwer Health, U.S. sales of TRILIPIX® were approximately $276 million across both strengths for the twelve month period ending January 2010.

Source
IMPAX Laboratories, Inc.

View drug information on Fenofibrate; Trilipix.


Article adapted by Medical News Today from original press release.
Visit our cholesterol section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
IMPAX Laboratories, Inc.. "Impax Laboratories Confirms Patent Challenge Relating To TRILIPIX(R) Delayed-Release Capsules, 135 Mg And 45 Mg." Medical News Today. MediLexicon, Intl., 17 Mar. 2010. Web.
25 May. 2012. <http://www.medicalnewstoday.com/releases/182479.php>

APA
IMPAX Laboratories, Inc.. (2010, March 17). "Impax Laboratories Confirms Patent Challenge Relating To TRILIPIX(R) Delayed-Release Capsules, 135 Mg And 45 Mg." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/182479.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Impax Laboratories Confirms Patent Challenge Relating To TRILIPIX(R) Delayed-Release Capsules, 135 Mg And 45 Mg'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




Cholesterol

What Is Cholesterol?

Cholesterol is a fat (lipid) which is produced by the liver and is crucial for normal body functioning. Cholesterol exists in the outer layer of every cell in our body and has many functions. Read more...

Most Popular Articles



Follow Our Cholesterol News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cholesterol Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »